Chart-Typ:
Zeitraum:
| EQS-News: Immunic AG: Immunic, Inc. to Participate in Investor Conference in December | Issuer: Immunic AG
/ Key word(s): Conference
Immunic, Inc. to Participate in Investor Conference in December
26.11.2024 / 12:30 CET/CEST
The issuer is solely responsible... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology | Issuer: Immunic AG
/ Key word(s): Scientific publication
Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Issuer: Immunic AG
/ Key word(s): Quarter Results
Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
07.11.2024 / 12:30 CET/CEST
The... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Third Quarter 2024 Business Update | ENGLEWOOD, Colo., Nov. 14, 2024 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace" or the "Company") today provided a business update and announced... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Second Quarter 2024 Business Update | ENGLEWOOD, Colo., Aug. 14, 2024 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announces a business update and the filing of its quarterly report on... ► Artikel lesen |
| Applied DNA Sciences, Inc.: Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA | - Regulatory Approval Showcases Clinical Advancement of Linea DNA as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences... ► Artikel lesen |
| Applied DNA Sciences: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines | - Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed by January 9, 2025 -- Webcast and Conference Call... ► Artikel lesen |
| Applied DNA Sciences, Inc.: Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Bu | STONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AGRIFY CORPORATION finden Sie auf Wallstreet Online.
